Obici Named Reading Campus Scientific Director
Silvana Obici, MD, associate professor in the division of endocrinology, diabetes and metabolism, has been named scientific director of the College of Medicines Reading Campus operations. Obici will report to Stephen Strakowski, MD, senior associate dean for research.
In her role as scientific director, Obici will serve as the primary representative of the College of Medicine programs based at UCs Reading Campus, including the programs collectively recognized as the Metabolic Diseases Institute.
She will build on existing programs and enfranchise othersboth within and outside the collegewhich are or will be co-located in Reading. Obici will serve as the primary interface with the key faculty of those programs and will serve as the faculty partner to the campus administrative director.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.